Adma Biologics Inc

Organisation

465 State Route 17, Ramsey, NJ, United States, 07446

Headquarters

Employees

Health Technology

Industry

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Price

Target

Adma Biologics Inc (ADMA) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Adma Biologics Inc (ADMA) share price will touch around $25.67 in next 12-months.

Currently 10 wall-street analysts regularly analyze the financials of Adma Biologics Inc on a frequent basis to provide recommendations along with target share price. 10 analysts offering 12-month price forecasts for Adma Biologics Inc (ADMA) have a share price target of $25.67. This median of share price forecast represents a 69.53% upside from the latest price of $15.14 as on 16.03.26.

Adma Biologics Inc (ADMA) Share Price Forecast

Home

US Stocks

Adma Biologics Inc (ADMA)

Adma Biologics Inc Stock Forecast

Adma Biologics Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Adma Biologics Inc (ADMA): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Adma Biologics Inc's share price and its median forecast price. As on 16.03.26, the difference is -24.49%

Adma Biologics Inc Forecast and Target Price

Adma Biologics Inc (ADMA) Share Price Forecast

Adma Biologics Inc (ADMA) Price vs Consensus Price Target

Adma Biologics Inc (ADMA) Share Price Forecast v/s Share Price Today

Adma Biologics Inc (ADMA): Difference between Current Price & Median Forecasted Price

Adma Biologics Inc (ADMA) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price